Autoimmune Disease Diagnosis Market by Product (Consumables, Assay Kits, Instruments), Test Type (Inflammatory Markers, Routine Laboratory Tests), Disease (RA, SLE, Thyroiditis, Scleroderma), End User (Hospitals, Clinical Labs) – Global Forecast to 2025
“The global autoimmune disease diagnosis market size is projected to register a CAGR of 8.9% during the forecast period.”
The global autoimmune disease diagnosis market size is projected to reach USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%. Growth in this industry is driven by the rising incidence of chronic diseases and the increasing demand for autoimmune disease diagnosis due to their cost-effectiveness. On the other hand, complexities in manufacturing restraining the market.
“The consumables &assay kits segment is anticipated to grow at the fastest growth rate during the forecast period.”
The autoimmune disease diagnosis market by product is categorized into consumables & assay kits and instruments. The consumables & assay kits segment is expected to register the highest CAGR during the forecast period. The growth of this segment is driven mainly by the increasing number of product launches/approvals, rising incidences of autoimmune diseases.
“The routine laboratory tests segment is estimated to grow at a rapid rate during the analysis period.”
Based on the test type, the autoimmune disease diagnosis market is segmented into routine laboratory tests, inflammatory markers, autoantibodies & immunologic tests, and other tests. The routine laboratory tests segment is expected to remain the fastest-growing segment of the global market during the autoimmune disease diagnosis period. The increasing number of regular health checkups, growing government initiatives to promote the importance of early disease diagnosis, are driving growth.
“Asia Pacific is estimated to register the highest CAGR during the study period.”
Geographically, the autoimmune disease diagnosis market is dominated by Europe and followed by North America in 2019. However, the Asia Pacific region is estimated to grow at the fastest rate during forecast to period. The rising aging population, coupled with the massive demand for effective diagnosis of autoimmune diseases, will drive the market in the region over the forecast period.
Breakdown of Profiles of Primary Participants:
Research Coverage:
The report analyzes the autoimmune disease diagnosis market by product, test type, disease, end user, and region. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.
Key Benefits of Buying the Report:
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one, or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
The global autoimmune disease diagnosis market size is projected to reach USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%. Growth in this industry is driven by the rising incidence of chronic diseases and the increasing demand for autoimmune disease diagnosis due to their cost-effectiveness. On the other hand, complexities in manufacturing restraining the market.
“The consumables &assay kits segment is anticipated to grow at the fastest growth rate during the forecast period.”
The autoimmune disease diagnosis market by product is categorized into consumables & assay kits and instruments. The consumables & assay kits segment is expected to register the highest CAGR during the forecast period. The growth of this segment is driven mainly by the increasing number of product launches/approvals, rising incidences of autoimmune diseases.
“The routine laboratory tests segment is estimated to grow at a rapid rate during the analysis period.”
Based on the test type, the autoimmune disease diagnosis market is segmented into routine laboratory tests, inflammatory markers, autoantibodies & immunologic tests, and other tests. The routine laboratory tests segment is expected to remain the fastest-growing segment of the global market during the autoimmune disease diagnosis period. The increasing number of regular health checkups, growing government initiatives to promote the importance of early disease diagnosis, are driving growth.
“Asia Pacific is estimated to register the highest CAGR during the study period.”
Geographically, the autoimmune disease diagnosis market is dominated by Europe and followed by North America in 2019. However, the Asia Pacific region is estimated to grow at the fastest rate during forecast to period. The rising aging population, coupled with the massive demand for effective diagnosis of autoimmune diseases, will drive the market in the region over the forecast period.
Breakdown of Profiles of Primary Participants:
- By Company Type: Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
- By Designation: C-level: 30%, Director-level: 34%, and Others: 36%
- By Region: North America: 40%, Europe: 28%, Asia Pacific: 20%, and the Rest of the World: 12%
Research Coverage:
The report analyzes the autoimmune disease diagnosis market by product, test type, disease, end user, and region. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.
Key Benefits of Buying the Report:
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one, or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the services of the top players in the autoimmune disease diagnosis market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the autoimmune disease diagnosis market
- Market Development: Detailed information about emerging markets.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the autoimmune disease diagnosis market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 GROWTH FORECAST
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE AUTOIMMUNE
DISEASE DIAGNOSIS MARKET
4.2 ASIA PACIFIC MARKET: BY DISEASE
4.3 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GEOGRAPHIC SNAPSHOT
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 High incidence and prevalence of autoimmune diseases
5.2.1.2 Increasing awareness about autoimmune diseases
5.2.1.3 Growth in the number of research activities on autoimmune diseases
5.2.2 RESTRAINTS
5.2.2.1 High capital requirements
5.2.3 OPPORTUNITIES
5.2.3.1 Use of biosensors for autoimmune disease diagnosis
5.2.4 TRENDS
5.2.4.1 Growth in the number of reagent rental agreements
6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONSUMABLES & ASSAY KITS
6.2.1 NEED FOR THE RAPID DETECTION OF AUTOIMMUNE DISEASES TO DRIVE
THE DEMAND FOR CONSUMABLES AND ASSAY KITS
6.3 INSTRUMENTS
6.3.1 INSTRUMENTS SEGMENT TO RECORD SIGNIFICANT GROWTH DURING THE FORECAST PERIOD
7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE
7.1 INTRODUCTION
7.2 ROUTINE LABORATORY TESTS
7.2.1 RISING NUMBER OF ROUTINE HEALTH CHECK-UPS TO
SUPPORT MARKET GROWTH
7.3 INFLAMMATORY MARKERS
7.3.1 ABILITY OF INFLAMMATORY MARKERS TO DETECT ABNORMALITIES EFFICIENTLY TO DRIVE THEIR DEMAND
7.4 AUTOANTIBODIES AND IMMUNOLOGIC TESTS
7.4.1 ADOPTION OF NOVEL IMMUNOLOGY TESTS TO DRIVE MARKET GROWTH
7.5 OTHER TESTS
8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE
8.1 INTRODUCTION
8.2 RHEUMATOID ARTHRITIS
8.2.1 INCREASING INCIDENCE OF RHEUMATOID ARTHRITIS TO
SUPPORT MARKET GROWTH
8.3 SYSTEMIC LUPUS ERYTHEMATOSUS
8.3.1 RISING PREVALENCE OF LUPUS TO SUPPORT MARKET GROWTH
8.4 SJ?GREN’S SYNDROME
8.4.1 RISING AWARENESS REGARDING SJ?GREN’S SYNDROME TO
SUPPORT MARKET GROWTH
8.5 THYROIDITIS
8.5.1 RISING PREVALENCE OF THYROID DISORDERS TO DRIVE MARKET GROWTH
8.6 SCLERODERMA
8.6.1 INCREASING INCIDENCE OF SKIN DISORDERS TO DRIVE MARKET GROWTH
8.7 OTHER DISEASES
9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER
9.1 INTRODUCTION
9.2 CLINICAL LABORATORIES
9.2.1 INCREASING INCIDENCE OF AUTOIMMUNE DISEASES TO INCREASE TESTING VOLUME IN CLINICAL LABORATORIES
9.3 HOSPITALS
9.3.1 INCREASING GOVERNMENT INITIATIVES TO PROVIDE QUALITY TREATMENT FOR AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH
9.4 OTHER END USERS
10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Rising expenditure on autoimmune disease R&D to drive market growth in the US
10.2.2 CANADA
10.2.2.1 Rising prevalence of autoimmune diseases to support market growth
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Rising healthcare expenditure to drive market growth in Germany
10.3.2 UK
10.3.2.1 Rising prevalence of autoimmune diseases to drive market growth in the UK
10.3.3 FRANCE
10.3.3.1 High prevalence of multiple sclerosis to drive market growth in France
10.3.4 ITALY
10.3.4.1 Increasing life science R&D expenditure to support market
growth in Italy
10.3.5 SPAIN
10.3.5.1 Research activities conducted in the country to drive market growth in Spain
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Outbreak of COVID-19 to hamper market growth during the
forecast period
10.4.2 INDIA
10.4.2.1 Development of antibody tests to support market growth in India
10.4.3 JAPAN
10.4.3.1 Rising healthcare expenditure to support market growth in Japan
10.4.4 AUSTRALIA
10.4.4.1 Rising prevalence of autoimmune diseases to drive market growth
in Australia
10.4.5 REST OF ASIA PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 RISING INCIDENCE OF AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH IN THE MIDDLE EAST AND AFRICA
10.6 LATIN AMERICA
10.6.1 HIGH PREVALENCE OF RHEUMATOID ARTHRITIS TO SUPPORT MARKET GROWTH IN LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS, 2018
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES (2017-2020)
11.3.2 PRODUCT APPROVALS (2017-2020)
11.3.3 PARTNERSHIPS
11.3.4 ACQUISITIONS (2017-2020)
11.3.5 COLLABORATIONS (2017-2020)
11.4 COMPETITIVE LEADERSHIP MAPPING (2018)
11.4.1 VISIONARY LEADERS
11.4.2 INNOVATORS
11.4.3 DYNAMIC DIFFERENTIATORS
11.4.4 EMERGING COMPANIES
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1 THERMO FISHER SCIENTIFIC
12.2 SIEMENS
12.3 ABBOTT
12.4 DANAHER
12.5 BIO-RAD LABORATORIES
12.6 GRIFOLS
12.7 TRINITY BIOTECH
12.8 WERFEN
12.9 HYCOR BIOMEDICAL
12.10 EUROIMMUN
12.11 ONCIMMUNE
12.12 HTG MOLECULAR DIAGNOSTICS, INC.
12.13 SERAMUN DIAGNOSTICA GMBH
12.14 EXAGEN INC.
12.15 CAMBRIDGE LIFE SCIENCES LIMITED
12.16 A. MENARINI DIAGNOSTICS S.R.L
12.17 ORGENTEC DIAGNOSTIKA
12.18 KRONUS
12.19 ERBA GROUP
12.20 AESKU.GROUP GMBH & CO. KG
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 GROWTH FORECAST
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE AUTOIMMUNE
DISEASE DIAGNOSIS MARKET
4.2 ASIA PACIFIC MARKET: BY DISEASE
4.3 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GEOGRAPHIC SNAPSHOT
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 High incidence and prevalence of autoimmune diseases
5.2.1.2 Increasing awareness about autoimmune diseases
5.2.1.3 Growth in the number of research activities on autoimmune diseases
5.2.2 RESTRAINTS
5.2.2.1 High capital requirements
5.2.3 OPPORTUNITIES
5.2.3.1 Use of biosensors for autoimmune disease diagnosis
5.2.4 TRENDS
5.2.4.1 Growth in the number of reagent rental agreements
6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONSUMABLES & ASSAY KITS
6.2.1 NEED FOR THE RAPID DETECTION OF AUTOIMMUNE DISEASES TO DRIVE
THE DEMAND FOR CONSUMABLES AND ASSAY KITS
6.3 INSTRUMENTS
6.3.1 INSTRUMENTS SEGMENT TO RECORD SIGNIFICANT GROWTH DURING THE FORECAST PERIOD
7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE
7.1 INTRODUCTION
7.2 ROUTINE LABORATORY TESTS
7.2.1 RISING NUMBER OF ROUTINE HEALTH CHECK-UPS TO
SUPPORT MARKET GROWTH
7.3 INFLAMMATORY MARKERS
7.3.1 ABILITY OF INFLAMMATORY MARKERS TO DETECT ABNORMALITIES EFFICIENTLY TO DRIVE THEIR DEMAND
7.4 AUTOANTIBODIES AND IMMUNOLOGIC TESTS
7.4.1 ADOPTION OF NOVEL IMMUNOLOGY TESTS TO DRIVE MARKET GROWTH
7.5 OTHER TESTS
8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE
8.1 INTRODUCTION
8.2 RHEUMATOID ARTHRITIS
8.2.1 INCREASING INCIDENCE OF RHEUMATOID ARTHRITIS TO
SUPPORT MARKET GROWTH
8.3 SYSTEMIC LUPUS ERYTHEMATOSUS
8.3.1 RISING PREVALENCE OF LUPUS TO SUPPORT MARKET GROWTH
8.4 SJ?GREN’S SYNDROME
8.4.1 RISING AWARENESS REGARDING SJ?GREN’S SYNDROME TO
SUPPORT MARKET GROWTH
8.5 THYROIDITIS
8.5.1 RISING PREVALENCE OF THYROID DISORDERS TO DRIVE MARKET GROWTH
8.6 SCLERODERMA
8.6.1 INCREASING INCIDENCE OF SKIN DISORDERS TO DRIVE MARKET GROWTH
8.7 OTHER DISEASES
9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER
9.1 INTRODUCTION
9.2 CLINICAL LABORATORIES
9.2.1 INCREASING INCIDENCE OF AUTOIMMUNE DISEASES TO INCREASE TESTING VOLUME IN CLINICAL LABORATORIES
9.3 HOSPITALS
9.3.1 INCREASING GOVERNMENT INITIATIVES TO PROVIDE QUALITY TREATMENT FOR AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH
9.4 OTHER END USERS
10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Rising expenditure on autoimmune disease R&D to drive market growth in the US
10.2.2 CANADA
10.2.2.1 Rising prevalence of autoimmune diseases to support market growth
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Rising healthcare expenditure to drive market growth in Germany
10.3.2 UK
10.3.2.1 Rising prevalence of autoimmune diseases to drive market growth in the UK
10.3.3 FRANCE
10.3.3.1 High prevalence of multiple sclerosis to drive market growth in France
10.3.4 ITALY
10.3.4.1 Increasing life science R&D expenditure to support market
growth in Italy
10.3.5 SPAIN
10.3.5.1 Research activities conducted in the country to drive market growth in Spain
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Outbreak of COVID-19 to hamper market growth during the
forecast period
10.4.2 INDIA
10.4.2.1 Development of antibody tests to support market growth in India
10.4.3 JAPAN
10.4.3.1 Rising healthcare expenditure to support market growth in Japan
10.4.4 AUSTRALIA
10.4.4.1 Rising prevalence of autoimmune diseases to drive market growth
in Australia
10.4.5 REST OF ASIA PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 RISING INCIDENCE OF AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH IN THE MIDDLE EAST AND AFRICA
10.6 LATIN AMERICA
10.6.1 HIGH PREVALENCE OF RHEUMATOID ARTHRITIS TO SUPPORT MARKET GROWTH IN LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS, 2018
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES (2017-2020)
11.3.2 PRODUCT APPROVALS (2017-2020)
11.3.3 PARTNERSHIPS
11.3.4 ACQUISITIONS (2017-2020)
11.3.5 COLLABORATIONS (2017-2020)
11.4 COMPETITIVE LEADERSHIP MAPPING (2018)
11.4.1 VISIONARY LEADERS
11.4.2 INNOVATORS
11.4.3 DYNAMIC DIFFERENTIATORS
11.4.4 EMERGING COMPANIES
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1 THERMO FISHER SCIENTIFIC
12.2 SIEMENS
12.3 ABBOTT
12.4 DANAHER
12.5 BIO-RAD LABORATORIES
12.6 GRIFOLS
12.7 TRINITY BIOTECH
12.8 WERFEN
12.9 HYCOR BIOMEDICAL
12.10 EUROIMMUN
12.11 ONCIMMUNE
12.12 HTG MOLECULAR DIAGNOSTICS, INC.
12.13 SERAMUN DIAGNOSTICA GMBH
12.14 EXAGEN INC.
12.15 CAMBRIDGE LIFE SCIENCES LIMITED
12.16 A. MENARINI DIAGNOSTICS S.R.L
12.17 ORGENTEC DIAGNOSTIKA
12.18 KRONUS
12.19 ERBA GROUP
12.20 AESKU.GROUP GMBH & CO. KG
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 2 AUTOIMMUNE DISEASE DIAGNOSIS CONSUMABLES & ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 3 AUTOIMMUNE DISEASE DIAGNOSIS INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 4 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 5 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR ROUTINE LABORATORY TESTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR INFLAMMATORY MARKERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR AUTOANTIBODIES AND IMMUNOLOGIC TESTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER TESTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SJ?GREN’S SYNDROME, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR THYROIDITIS, BY REGION, 2018–2025 (USD MILLION)
TABLE 14 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SCLERODERMA, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER DISEASES, BY REGION, 2018–2025 (USD MILLION)
TABLE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 17 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR HOSPITALS, BY REGION, 2018–2025 (USD MILLION)
TABLE 19 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 23 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 24 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 25 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 26 EXPENDITURE ON AUTOIMMUNE DISEASE R&D BY THE NATIONAL INSTITUTES OF HEALTH, 2016–2019
TABLE 27 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 28 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 29 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 30 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 31 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 32 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 33 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 34 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 35 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 37 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 38 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 39 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 40 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 41 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 42 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 43 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 44 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 45 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 46 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 47 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 48 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 49 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 50 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 51 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 52 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 53 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 54 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 55 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 56 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 57 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 58 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 59 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 60 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 61 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 62 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 63 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 64 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 66 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 67 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 68 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 69 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 70 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 71 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 72 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 73 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 74 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 75 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 76 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 77 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 78 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 79 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 80 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 81 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 82 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 83 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 84 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 85 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 86 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 87 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 88 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 92 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 93 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 94 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 95 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 96 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 2 AUTOIMMUNE DISEASE DIAGNOSIS CONSUMABLES & ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 3 AUTOIMMUNE DISEASE DIAGNOSIS INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 4 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 5 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR ROUTINE LABORATORY TESTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR INFLAMMATORY MARKERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR AUTOANTIBODIES AND IMMUNOLOGIC TESTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER TESTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SJ?GREN’S SYNDROME, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR THYROIDITIS, BY REGION, 2018–2025 (USD MILLION)
TABLE 14 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SCLERODERMA, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER DISEASES, BY REGION, 2018–2025 (USD MILLION)
TABLE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 17 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR HOSPITALS, BY REGION, 2018–2025 (USD MILLION)
TABLE 19 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 23 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 24 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 25 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 26 EXPENDITURE ON AUTOIMMUNE DISEASE R&D BY THE NATIONAL INSTITUTES OF HEALTH, 2016–2019
TABLE 27 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 28 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 29 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 30 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 31 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 32 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 33 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 34 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 35 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 37 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 38 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 39 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 40 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 41 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 42 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 43 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 44 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 45 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 46 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 47 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 48 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 49 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 50 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 51 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 52 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 53 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 54 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 55 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 56 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 57 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 58 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 59 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 60 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 61 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 62 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 63 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 64 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 66 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 67 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 68 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 69 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 70 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 71 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 72 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 73 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 74 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 75 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 76 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 77 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 78 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 79 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 80 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 81 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 82 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 83 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 84 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 85 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 86 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 87 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 88 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 92 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 93 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 94 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 95 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 96 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
LIST OF FIGURES
FIGURE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 5 MARKET SIZE ESTIMATION FROM THE PARENT MARKET
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 ASSUMPTIONS FOR THE STUDY
FIGURE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 12 GEOGRAPHIC SNAPSHOT OF THE GLOBAL AUTOIMMUNE DISEASE
DIAGNOSIS MARKET
FIGURE 13 HIGH INCIDENCE & LARGE ECONOMIC BURDEN OF AUTOIMMUNE DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 14 RHEUMATOID ARTHRITIS SEGMENT DOMINATED THE APAC MARKET IN 2019
FIGURE 15 JAPAN TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & TRENDS
FIGURE 17 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT
FIGURE 18 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT
FIGURE 19 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT
FIGURE 20 PRODUCT LAUNCHES–THE MOST ADOPTED GROWTH STRATEGY
FROM 2017 TO 2020
FIGURE 21 SHARES OF TOP COMPANIES IN THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET (2018)
FIGURE 22 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 24 SIEMENS: COMPANY SNAPSHOT
FIGURE 25 ABBOTT: COMPANY SNAPSHOT
FIGURE 26 DANAHER: COMPANY SNAPSHOT
FIGURE 27 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
FIGURE 28 GRIFOLS: COMPANY SNAPSHOT
FIGURE 29 TRINITY BIOTECH: COMPANY SNAPSHOT
FIGURE 30 WERFEN: COMPANY SNAPSHOT
FIGURE 31 PERKINELMER, INC.: COMPANY SNAPSHOT
FIGURE 32 ONCIMMUNE: COMPANY SNAPSHOT
FIGURE 33 HTG MOLECULAR DIAGNOSTICS, INC.: COMPANY SNAPSHOT
FIGURE 34 EXAGEN INC.: COMPANY SNAPSHOT
FIGURE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 5 MARKET SIZE ESTIMATION FROM THE PARENT MARKET
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 ASSUMPTIONS FOR THE STUDY
FIGURE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 12 GEOGRAPHIC SNAPSHOT OF THE GLOBAL AUTOIMMUNE DISEASE
DIAGNOSIS MARKET
FIGURE 13 HIGH INCIDENCE & LARGE ECONOMIC BURDEN OF AUTOIMMUNE DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 14 RHEUMATOID ARTHRITIS SEGMENT DOMINATED THE APAC MARKET IN 2019
FIGURE 15 JAPAN TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & TRENDS
FIGURE 17 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT
FIGURE 18 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT
FIGURE 19 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT
FIGURE 20 PRODUCT LAUNCHES–THE MOST ADOPTED GROWTH STRATEGY
FROM 2017 TO 2020
FIGURE 21 SHARES OF TOP COMPANIES IN THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET (2018)
FIGURE 22 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 24 SIEMENS: COMPANY SNAPSHOT
FIGURE 25 ABBOTT: COMPANY SNAPSHOT
FIGURE 26 DANAHER: COMPANY SNAPSHOT
FIGURE 27 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
FIGURE 28 GRIFOLS: COMPANY SNAPSHOT
FIGURE 29 TRINITY BIOTECH: COMPANY SNAPSHOT
FIGURE 30 WERFEN: COMPANY SNAPSHOT
FIGURE 31 PERKINELMER, INC.: COMPANY SNAPSHOT
FIGURE 32 ONCIMMUNE: COMPANY SNAPSHOT
FIGURE 33 HTG MOLECULAR DIAGNOSTICS, INC.: COMPANY SNAPSHOT
FIGURE 34 EXAGEN INC.: COMPANY SNAPSHOT
